Correlation Between Aldeyra and Eton Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aldeyra and Eton Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldeyra and Eton Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aldeyra and Eton Pharmaceuticals, you can compare the effects of market volatilities on Aldeyra and Eton Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldeyra with a short position of Eton Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldeyra and Eton Pharmaceuticals.

Diversification Opportunities for Aldeyra and Eton Pharmaceuticals

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aldeyra and Eton is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Aldeyra and Eton Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eton Pharmaceuticals and Aldeyra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldeyra are associated (or correlated) with Eton Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eton Pharmaceuticals has no effect on the direction of Aldeyra i.e., Aldeyra and Eton Pharmaceuticals go up and down completely randomly.

Pair Corralation between Aldeyra and Eton Pharmaceuticals

Given the investment horizon of 90 days Aldeyra is expected to under-perform the Eton Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Aldeyra is 1.01 times less risky than Eton Pharmaceuticals. The stock trades about -0.12 of its potential returns per unit of risk. The Eton Pharmaceuticals is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest  842.00  in Eton Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of  361.00  from holding Eton Pharmaceuticals or generate 42.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aldeyra  vs.  Eton Pharmaceuticals

 Performance 
       Timeline  
Aldeyra 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aldeyra has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Aldeyra is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Eton Pharmaceuticals 

Risk-Adjusted Performance

29 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eton Pharmaceuticals are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Eton Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Aldeyra and Eton Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aldeyra and Eton Pharmaceuticals

The main advantage of trading using opposite Aldeyra and Eton Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldeyra position performs unexpectedly, Eton Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will offset losses from the drop in Eton Pharmaceuticals' long position.
The idea behind Aldeyra and Eton Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Money Managers
Screen money managers from public funds and ETFs managed around the world